For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Nitrofurantion Macrocrystals Capsule and its risk associated with lactation. We will also discuss the usage of Nitrofurantion Macrocrystals Capsule and some common side effects associated with Nitrofurantion Macrocrystals Capsule.
What is Nitrofurantion Macrocrystals Capsule used for?
Nitrofurantoin Macrocrystals is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nitrofurantoin Macrocrystals and other antibacterial drugs, Nitrofurantoin Macrocrystals should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with Nitrofurantoin Macrocrystals are predisposed to persistence or reappearance of bacteriuria. Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with Nitrofurantoin Macrocrystals, other therapeutic agents with broader tissue distribution should be selected. In considering the use of Nitrofurantoin Macrocrystals, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.
Nitrofurantion Macrocrystals Capsule while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?
Nitrofurantoin is the only one ingredient used in manufacturing of Nitrofurantion Macrocrystals Capsule, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Nitrofurantoin it is safe to use Nitrofurantion Macrocrystals Capsule while lactating. We suggest you to check further details below about Nitrofurantoin usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Nitrofurantoin has been detected in human breast milk in trace amounts. Because of the potential for serious adverse reactions from nitrofurantoin in nursing infants under one month of age, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother (see CONTRAINDICATIONS).
Nitrofurantion Macrocrystals Capsule Breastfeeding Analsys
Nitrofurantoin while Breastfeeding Safe
CAS Number: 67-20-9
Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.
Nitrofurantion Macrocrystals Capsule Breastfeeding Analsys - 2
Nitrofurantoin while Breastfeeding
CAS Number: 67-20-9
Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth. Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.
What should I do if I am breastfeeding mother and I am already exposed to Nitrofurantion Macrocrystals Capsule?
Nitrofurantion Macrocrystals Capsule is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Nitrofurantion Macrocrystals Capsule you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
I am nursing mother and my doctor has suggested me to use Nitrofurantion Macrocrystals Capsule, is it safe?
Definitely, Nitrofurantion Macrocrystals Capsule is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Nitrofurantion Macrocrystals Capsule, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Nitrofurantion Macrocrystals Capsule
Who can I talk to if I have questions about usage of Nitrofurantion Macrocrystals Capsule in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week